


Pinpoint clinically relevant variants in seconds. Filter, prioritize, and act with confidence.

See exactly where your sequencing hits and where it doesn't, so nothing gets missed.

Visualize patient data in full genomic context, right alongside your annotations and tracks.

Surface the research that matters most, automatically matched to your variants and genes.
Identify acquired mutations in cancers.
Pinpoint germline variants.
Detect microbial pathogens.
Your data stays yours—never shared, never sold. Our patented double-encryption system secures each patient file with a unique key for maximum data protection. You stay safe, compliant, and in control.
SeqOne Platform is a Class C, CE-IVDR certified in vitro diagnostic medical device, manufactured by SeqOne SAS (France). In the United Kingdom, SeqOne Platform is distributed under the Congenica brand by Congenica Ltd, a UK affiliate of SeqOne SAS. Congenica Ltd acts as the UK Responsible Person in accordance with UK MDR 2002.The company is certified under ISO 13485 for medical device manufacturer, and under ISO 27001 for information security and health data hosting.

With 92% specificity, SmartPick instantly suggests the most likely disease-causing variants

*Study on singleton with HPOs

Achieve diagnosis in record time with 90% of causal variants ranked in the top 3.

Validate Congenica with your own data, expert support, and zero commitment.
Pay-per-analysis with no hidden fees or volume constraints.

Access field specialists, multi-lingual assistance and hands-on guidance.